Salmonella non-typhi
Showing 1 - 25 of >10,000
Typhoid Fever Trial (TYP04A Low Dose without adjuvant investigational vaccine, TYP04B Full Dose without adjuvant investigational
Not yet recruiting
- Typhoid Fever
- TYP04A Low Dose without adjuvant investigational vaccine
- +5 more
- (no location specified)
Nov 4, 2022
Trivalent Salmonella Conjugate Vaccine (TSCV) Trial (TSCV (Full-strength), TSCV (Half-strength), Typbar-TCV)
Not yet recruiting
- Trivalent Salmonella Conjugate Vaccine (TSCV)
- TSCV (Full-strength)
- +3 more
- (no location specified)
Mar 24, 2023
Typhoid Fever, Paratyphoid Fever Trial in Oxford (Salmonella Typhi, Salmonella Paratyphi)
Completed
- Typhoid Fever
- Paratyphoid Fever
- Salmonella Typhi
- Salmonella Paratyphi
-
Oxford, Oxfordshire, United KingdomOxford Vaccine Group
May 30, 2022
Salmonella Typhi Infection Trial in Oxford (Salmonella Typhi challenge)
Completed
- Salmonella Typhi Infection
- Salmonella Typhi challenge
-
Oxford, Oxfordshire, United KingdomCentre for Clinical Vaccinology and Tropical Medicine (CCVTM)
Feb 8, 2022
Salmonella Infections, Salmonella Typhimurium, Non-typhoidal Salmonella (NTS) Trial in London (Salmonella Typhimurium)
Not yet recruiting
- Salmonella Infections
- +7 more
- Salmonella Typhimurium
-
London, England, United KingdomImperial College London
May 11, 2023
Salmonella Typhi Infection Trial in Oxford (Salmonella Typhi (S. Typhi))
Unknown status
- Salmonella Typhi Infection
- Salmonella Typhi (S. Typhi)
-
Oxford, Oxfordshire, United KingdomOxford Vaccine Group, Centre for Clinical Vaccinology and Tropic
Dec 9, 2021
Treating Non-typhoidal Salmonella Bloodstream Infections in
Completed
- Blood-stream Infections
- Salmonella Infection Non-Typhoid
- Observational Cohort
-
Kisantu, Congo, The Democratic Republic of theKisantu Hospital
Sep 6, 2022
Risk Reduction Trial in Baltimore (Trivalent Invasive Salmonella Disease Vaccine (6.25 µg), Trivalent Invasive Salmonella
Completed
- Risk Reduction
- Trivalent Invasive Salmonella Disease Vaccine (6.25 µg)
- +4 more
-
Baltimore, MarylandUniversity of Maryland, Baltimore, Center for Vaccine Developmen
Oct 25, 2021
Immune Deficiency Trial in Charlottesville (Salmonella typhi polysaccharide vaccine)
Recruiting
- Immune Deficiency
- Salmonella typhi polysaccharide vaccine
-
Charlottesville, VirginiaUniversity of Virginia Health System
May 16, 2022
Malaria Trial in Bamako (Pfs230D1M-EPA/AS01, HAVRIX, TYPHIM Vi (Salmonella typhi vaccine))
Active, not recruiting
- Malaria
- Pfs230D1M-EPA/AS01
- +4 more
-
Bamako, MaliMrtc/Usttb
Jul 29, 2022
Commercial Typhoid Tests Validation
Not yet recruiting
- Typhoid Fever
- 1. SD Bioline Salmonella Typhi IgG/IgM Fast test, 2. Typhidot Rapid IgG/IgM combo test, 3. TUBEX TF test, 4.Typhoid IgG/IgM Combo Rapid Test CE, 5. Enterocheck WB test, 6. Test-itTM Typhoid IgM test
-
Nairobi, KenyaKenya Medical Research Institute
Dec 12, 2020
HIV, HIV Seronegativity Trial in Baltimore (Salmonella typhi CVD 908-HIV-1 LAI gp 120 (VVG 203), Aluminum hydroxide, MF59)
Completed
- HIV Infections
- HIV Seronegativity
- Salmonella typhi CVD 908-HIV-1 LAI gp 120 (VVG 203)
- +3 more
-
Baltimore, MarylandJHU AVEG
Oct 27, 2021
Health Itinerary of Young Suspected Bloodstream Infection in
Completed
- Bloodstream Infection
- +4 more
-
Kisantu, Congo, The Democratic Republic of theHôpital Saint-Luc Kisantu
Sep 6, 2022
Vaccine-Preventable Diseases, Typhoid Fever, Cholera Trial in Helsinki (Oral typhoid fever vaccine, Oral cholera vaccine)
Recruiting
- Vaccine-Preventable Diseases
- +2 more
- Oral typhoid fever vaccine
- Oral cholera vaccine
-
Helsinki, FinlandMeilahti Vaccine Research Center, Helsinki University Hospital
Oct 27, 2023
Iron Deficiency Anemia Trial (Iron-fortified cookies, Japanese encephalitis (JE) vaccine, Typhoid Vi polysaccharide (Vi-PS)
Not yet recruiting
- Iron Deficiency Anemia
- Iron-fortified cookies
- +3 more
- (no location specified)
Aug 30, 2023
Evaluation Study of DPP® Typhoid Assay
Recruiting
- Typhoid Fever
- Typhoid DPP assay
-
Karachi, PakistanAga Khan University
Oct 11, 2022
Typhoid Conjugate Vaccine Introduction in Navi Mumbai, India
Completed
- Enteric Fever
- +2 more
- Typhoid Conjugate Vaccine
-
Navi Mumbai, India
- +5 more
Sep 30, 2021
Commercial Typhoid Tests Validation Trial
Completed
- Typhoid Fever
- Rapid diagnostic tests
-
Nairobi, Kenya
- +1 more
May 23, 2022
Cancer of the Liver, Liver Cancer, Hepatoma Trial in Minneapolis (Salmonella typhimurium)
Completed
- Cancer of the Liver
- +4 more
- Salmonella typhimurium
-
Minneapolis, MinnesotaEdward W. Greeno, MD
Jul 6, 2020
Salmonella Infections Trial (biological, combination product, drug, other)
Not yet recruiting
- Salmonella Infections
- Invasive nontyphoidal Salmonella-typhoid conjugate vaccine (iNTS-TCV) low dose
- +10 more
- (no location specified)
Jul 27, 2022
Biliary Atresia, Cholangitis, Anti-Bacterial Agents Trial (Basic treatment: sulperazone + ursodeoxycholic acid + compound
Not yet recruiting
- Biliary Atresia
- +2 more
- Basic treatment: sulperazone + ursodeoxycholic acid + compound glycyrrhizin + methylprednisolone + vitamin AD , D , E , K + imipenem or meropenem
- Prophylactic oral antibiotics: compound sulfamethoxazole tablet (SMZ/TMP) + cefaclor
- (no location specified)
Jun 28, 2023
Sanitation and Oral Rotavirus Vaccine Performance
Recruiting
- Rotavirus Infections
- +2 more
- Sanitation
-
Maputo, MozambiqueCentro de Investigação em Saúde da Polana Caniço (CISPOC)
May 16, 2022
Typhoid Trial in Dhaka (Typhoid Vi polysaccharide-diphtheria toxoid conjugate vaccine (Vi-DT))
Not yet recruiting
- Typhoid
- Typhoid Vi polysaccharide-diphtheria toxoid conjugate vaccine (Vi-DT)
-
Dhaka, BangladeshInternational Centre for Diarrhoeal Disease Research, Bangladesh
Jul 25, 2022
Clinical Evaluation of the FilmArray® Global Fever (GF) Panel
Active, not recruiting
- Fever
- Observational study
-
Washington, District of Columbia
- +10 more
Nov 16, 2021
Metastatic Pancreatic Cancer Trial in Montreal (Salmonella-IL2, FOLFIRINOX Alone (Historical Controls), Gemcitabine/Abraxane
Recruiting
- Metastatic Pancreatic Cancer
- Salmonella-IL2
- +2 more
-
Montreal, Quebec, CanadaSegal Cancer Centre/ Mortimer B. Davis-Jewish General Hosptial
May 3, 2022